Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)

SHA:688266 Statistics

Total Valuation

SHA:688266 has a market cap or net worth of CNY 23.68 billion. The enterprise value is 22.71 billion.

Market Cap	23.68B
Enterprise Value	22.71B

Important Dates

The next estimated earnings date is Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	n/a

Share Statistics

SHA:688266 has 264.71 million shares outstanding. The number of shares has increased by 0.84% in one year.

Current Share Class	264.71M
Shares Outstanding	264.71M
Shares Change (YoY)	+0.84%
Shares Change (QoQ)	+6.69%
Owned by Insiders (%)	28.27%
Owned by Institutions (%)	25.51%
Float	157.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	31.90
PB Ratio	20.61
P/TBV Ratio	21.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-170.35
EV / Sales	30.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-109.23

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.98.

Current Ratio	1.85
Quick Ratio	1.68
Debt / Equity	0.98
Debt / EBITDA	n/a
Debt / FCF	-5.41
Interest Coverage	-28.01

Financial Efficiency

Return on equity (ROE) is -11.11% and return on invested capital (ROIC) is -5.52%.

Return on Equity (ROE)	-11.11%
Return on Assets (ROA)	-4.16%
Return on Invested Capital (ROIC)	-5.52%
Return on Capital Employed (ROCE)	-11.99%
Revenue Per Employee	815,689
Profits Per Employee	-146,532
Employee Count	910
Asset Turnover	0.25
Inventory Turnover	0.40

Taxes

Income Tax	-4.52M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.21% in the last 52 weeks. The beta is 0.14, so SHA:688266's price volatility has been lower than the market average.

Beta (5Y)	0.14
52-Week Price Change	+61.21%
50-Day Moving Average	105.79
200-Day Moving Average	98.91
Relative Strength Index (RSI)	48.85
Average Volume (20 Days)	3,723,914

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688266 had revenue of CNY 742.28 million and -133.34 million in losses. Loss per share was -0.50.

Revenue	742.28M
Gross Profit	674.63M
Operating Income	-198.83M
Pretax Income	-140.76M
Net Income	-133.34M
EBITDA	-155.15M
EBIT	-198.83M
Loss Per Share	-0.50

Balance Sheet

The company has 2.09 billion in cash and 1.13 billion in debt, giving a net cash position of 960.79 million or 3.63 per share.

Cash & Cash Equivalents	2.09B
Total Debt	1.13B
Net Cash	960.79M
Net Cash Per Share	3.63
Equity (Book Value)	1.15B
Book Value Per Share	4.09
Working Capital	1.15B

Cash Flow

In the last 12 months, operating cash flow was -45.18 million and capital expenditures -162.78 million, giving a free cash flow of -207.95 million.

Operating Cash Flow	-45.18M
Capital Expenditures	-162.78M
Free Cash Flow	-207.95M
FCF Per Share	-0.79

Margins

Gross margin is 90.89%, with operating and profit margins of -26.79% and -17.96%.

Gross Margin	90.89%
Operating Margin	-26.79%
Pretax Margin	-18.96%
Profit Margin	-17.96%
EBITDA Margin	-20.90%
EBIT Margin	-26.79%
FCF Margin	n/a

Dividends & Yields

SHA:688266 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.84%
Shareholder Yield	-0.84%
Earnings Yield	-0.56%
FCF Yield	-0.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2